On May 28, 2014, Array Biopharma Inc (NASDAQ:ARRY), announced a collaboration agreement with Biogen Idec (BIIB) for the discovery and development of inhibitors targeting a novel kinase for the treatment of autoimmune disorders. Array Biopharma Inc (NASDAQ:ARRY), weekly performance is 0.49%. On last trading day company shares ended up $4.12. Analysts mean target price for the company is $7.57. Array Biopharma Inc (NASDAQ:ARRY), distance from 50-day simple moving average (SMA50) is -1.18%.
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company focused on the development of innovative approaches to targeting and treating cancer, announced that Chief Executive Officer Mark Baker will present on Thursday, June 5th, at 10:00 AM EDT at the Jefferies Global Healthcare Conference in New York City. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), fell 4.68% in last trading session and ended the day on $3.88. PGNX, Gross Margin is 92.00% and its return on assets is -32.20%. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), quarterly performance is -17.66%.
On May 27, 2014, Northwest Biotherapeutics, Inc (NASDAQ:NWBO)’s shares jumped 5.61% to $6.16. The company on May 27 provided a summary of initial data to date in its ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors. The Company reported that over 50% of the patients who have completed at least half of the 6 treatments in the trial are already showing preliminary signs of cancer cell death, tumor shrinkage and/or stabilization (i.e., stopping the progression) of their advanced cancer. Northwest Biotherapeutics, Inc (NASDAQ:NWBO), shares moved down 6.52% in last trading session and was closed at $5.59, while trading in range of $5.41 – 5.98. Northwest Biotherapeutics, Inc (NASDAQ:NWBO), year to date (YTD) performance is 48.28%.
On May 28, 2014, Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), is the latest pharmaceutical company to be scrutinized by Chinese authorities, who are investigating foreign businesses for possible economic crimes conducted in the country. Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), ended the last trading day at $37.55.
Bayer AG (ADR) (OTCMKTS:BAYRY), has entered into a global agreement with Orion Corporation, a pharmaceutical company based in Espoo, Finland, (Nasdaq OMX Helsinki: ORNAV and ORNBV) for the development and commercialization of the compound ODM-201, an investigational novel oral androgen receptor inhibitor. Bayer AG (ADR) (OTCMKTS:BAYRY), on last trading day company shares ended up $144.81.